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sis between Dengue and Yellow Fever, which is absolutely
necessary for an effective surveillance and opportune epi-
demiologic measures.14th International Congress on Infectious Diseases (ICID) Abs
75.041
Evaluation of the C. DIFFICILE TOXIN A/B IITM, C. DIFF
CHEK-60TM, and PREMIER TOXIN A&BTM with the cyto-
toxin assay for the detection of Clostridium difﬁcile GDH
antigen and toxins A and B in feces
W. Greene
PennState Hershey Medical Center, Hershey, PA, USA
Background: C difﬁcile causes about 25% of the cases
of antibiotic-associated diarrhea and most cases of pseu-
domembranous colitis. Rapid assays have been developed to
detect the toxins A and B and the enzyme glutamate dehy-
drogenase which is produced in high levels by all strains of
the organism. Because this enzyme is present in both toxi-
genic and nontoxigenic strains of the organism, the assay can
not conﬁrm the presence of toxigenic organisms in a sample.
However, the absence of this enzyme in a sample should be
a good marker for the absence of the organism, making it a
suitable screening assay to identify negative specimens.
Methods: We compared two commercial EIA assays for
detecting toxins A and B, and an EIA assay for detecting the
GDH enzyme with our in-house cytotoxin assay as the ‘‘gold
standard.’’ All commercial assays were performed accord-
ing to the manufacturer’s instructions. span.jajahWrapper
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Results: Fecal samples (N = 236) submitted for C. difﬁcile
cytotoxin assay were included in this study. The C. DIFF
CHEK-60TM, detected all 10 of the cytotoxin positive
specimens and was positive for 28 specimens where cyto-
toxin was not detected by any of the toxin assays. The C.
DIFFICILE TOXIN A/B IITM detected all 10 of the cytotoxin
positive specimens and gave no false-positive results.
The PREMIER TOXIN A&BTM assay detected 9 cytotoxin
positive specimens and had 2 positive results that were
negative by all the other assays. span.jajahWrapper {font-
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Conclusion: The GDH assay detected 100% of the
cytotoxin positive specimens making it a useful assay for
screening specimens for detecting C difﬁcile. This would
allow for the rapid reporting of the negative specimens
that made up 84% of the specimens examined in this
study. GDH positive assays should then be tested with an
assay speciﬁc for the toxins. span.jajahWrapper {font-
size:1em; color:#B11196; text-decoration:underline;}
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highly sensitive reverse transcription polymerase chain
eaction method for yellow fever virus detection
. Méndez1,∗, C. Mendez2, C. Domingo3, G. Rey2, A.
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Background: Diagnosis of YF is an important issue particu-
arly in countries where it is endemic. Usual serological tests
nclude IgM antibody capture by enzyme-linked immunosor-
ent assay (MAC-ELISA), hemagglutination inhibition (HI),
omplement ﬁxation (CF) and neutralization (N). Neverthe-
ess, antibody detection is feasible only 5 to 6 days after
he offset of symptoms and the true usefulness is by eval-
ation of paired samples which are not easy to obtain. On
he other hand, speciﬁc diagnosis during infection period is
urrently done by isolation of virus in mosquito cells or by
enome detection through PCR based methods, while fatal
ases are conﬁrmed with immunohistochemistry with mono-
lonal antibodies over well conserved ﬁxed tissues. Although
iral isolation is a very speciﬁc technique, it takes at last 7
10 days and sensitivity decrease when few virus particles
re present in the sample or when toxic biliary salts present
n serum inhibit cell growth. Detection of virus in the acute
hase must be speciﬁc and sensible enough to conﬁrm the
iagnosis, and then start the surveillance measurements.
Methods: Twenty ﬁve human sera were processed with
he QIAamp Viral RNA Minikit. Reverse Transcription (RT) was
arried out following by Polymerase Chain Reaction (PCR)
sing speciﬁc primers designed to amplify 734 bp from the
rM/E junction. Negative samples were reampliﬁed with
nternal primers (nested PCR) to obtain a 692 bp fragment.
Results: The expected ampliﬁcation product size was
btained in 20 of 25 samples analyzed. Positive reaction
as obtained in 2 samples after ﬁrst reaction, while the
emaining 18 were positive after performing nested PCR.
Conclusion: This improved RT-PCR using primers designed
n a conserved region of genome to amplify short frag-
ents, not just ensure detection of all YFV genotypes,
ut also increase sensibility even in more difﬁcult samples.
emarkable, this reaction allows rapid differential diagno-oi:10.1016/j.ijid.2010.02.442
